Moderna stock rises as COVID shot gains market share on Pfizer - The Boston Globe

Retrieved on: 2024-02-22 14:45:55

Tags for this article:

COVID-19 vaccination in the United States

RNA vaccines

COVID-19 pandemic by country

Medical research

Moderna

Moderna COVID-19 vaccine

Respiratory syncytial virus vaccine

Vaccine

Pfizer-BioNTech COVID-19 vaccine

COVID-19 vaccine

Respiratory syncytial virus

Stéphane Bancel

Click the tags to see associated articles and topics

Moderna stock rises as COVID shot gains market share on Pfizer - The Boston Globe. View article details on hiswai: https://www.bostonglobe.com/2024/02/22/business/moderna-stock-pfizer/

Summary

Moderna, known for its COVID-19 vaccine, is expanding its portfolio with an RSV vaccine, aiming to build on its half US market share in COVID vaccines and maintain a strong presence alongside competitors in the rapidly evolving vaccination landscape.

Article found on: www.bostonglobe.com

View Original Article